FBXW11 and neoplasm: Specifically, circMAN1A2 competes with F-Box and WD repeat domain containing 11 (FBXW11) to bind and stabilize splicing factor proline and glutamine rich (SFPQ) expression, inhibiting T cell receptor stimulation and reducing T cell anti-tumor activity (47).